Announcements Trials

Browse Landscape

Phase

Status

Completed 8 Terminated 6 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 8 Neuroblastoma 5 Rhabdoid Tumor 3 Ovarian Neoplasms 3 Neoplasms 3 Fallopian Tube Neoplasms 3 Neoplasm Metastasis 2 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Sarcoma, Ewing 1 Sarcoma 1 SCLC 1 Rhabdomyosarcoma 1 Retinoblastoma 1 Recurrence 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Medulloblastoma 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Fallopian Tube Mucinous Adenocarcinoma 1 Epilepsy 1 Diffuse Intrinsic Pontine Glioma 1 Choroid Plexus Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Neuroendocrine 1

Interventions

Dexamethasone 18 Cyclophosphamide 16 fludarabine 11 pomalidomide 9 pembrolizumab 9 carfilzomib 9 daratumumab 7 Rituximab 7 Lenalidomide 7 Calcium Dobesilate 7 fludarabine phosphate 6 Gemcitabine 6 Cisplatin 6 Bortezomib 6 venetoclax 5 elotuzumab 4 isatuximab 3 blinatumomab 3 Vincristine 3 Radiotherapy 3 Prednisone 3 Etoposide 3 Doxorubicin 3 Cytarabine 3 tisagenlecleucel 2 selinexor 2 ruxolitinib 2 ixazomib 2 dexamethasone 21-phosphate 2 cabazitaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Recurrence × Topotecan × Clear all

NCT02298348 2026-03-23

N2013-02

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Active not recruiting

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡